AM |
Ampicillin. |
AMC |
Amoxicillin–clavulanate. |
ATM |
Aztreonam. |
CAZ |
Ceftazidime. |
CCs |
Clonal complexes. |
CEC |
Cefaclor. |
CF |
Cephalothin. |
CLSI |
Clinical and Laboratory Standard Institute. |
CRO |
Ceftriaxone. |
CTX-M |
Cefotaximase-M. |
CTX |
Cefotaxime. |
cUTIs |
Complicated urinary tract infections. |
ESBLs |
Extended-spectrum β-lactamases. |
F/M |
Nitrofurantoin. |
GM |
Gentamicin. |
IPM |
Imipenem. |
LVX |
Levofloxacin. |
MBLs |
Metallo-β-lactamases. |
MDR |
Multidrug-resistant. |
MEM |
Meropenem. |
MLST |
Multilocus Sequence Typing. |
NOR |
Norfloxacin. |
OFX |
Ofloxacin. |
PFGE |
Pulsed-field gel Electrophoresis. |
PLSD |
ANOVA Fisher’s protected least significant difference. |
SNP |
Single-nucleotide polymorphism. |
STs |
Sequence types. |
SXT |
Trimethoprim–sulfamethoxazole. |
TE |
Tetracycline. |
TZP |
Piperacillin–tazobactam. |
UPEC |
Uropathogenic Escherichia coli.
|
UPGMA |
Unweighted Pair-Cluster Method using Arithmetic Averages. |
UTIs |
Urinary tract infections. |
XDR |
Extremely drug-resistant. |